Exploring Inflammatory Myopathies and Recent FDA Approvals

This chapter analyzes the prevalence and under-reporting of inflammatory myopathies in regions like South Africa and Asia, while spotlighting findings on IL-1 inhibitors including anakinra. It also discusses the FDA's approval of cecukinumab for arthritic conditions and trends in arthritis prevalence among U.S. adults.